| abstract |
The object of the present invention is to provide novel compounds having ACC2 inhibiting activity. In addition, the object of the present invention is to provide a pharmaceutical composition comprising the compound. n A compound of formula (I): n n n n n n n n n n n n wherein R 1 is substituted or unsubstituted fused aromatic heterocyclyl etc., n n n ring A is substituted or unsubstituted non-aromatic carbocycle etc., n -L 1 - is —O—(CR 6 R 7 )m- etc., n -L 2 - is —O—(CR 6 R 7 )n- etc., n each R 6 and R 7 are independently hydrogen, halogen etc., n R 2 is substituted or unsubstituted alkyl, n R 3 is hydrogen or substituted or unsubstituted alkyl, n R 4 is substituted or unsubstituted alkylcarbonyl etc. |